STRATEGI RUMAH SAKIT DALAM MENGELOLA PERSEDIAAN FARMASI SELAMA PANDEMI COVID-19

  • Inaz Kemala Dewi Program Studi Kajian Administrasi Rumah Sakit, Fakultas Kesehatan Masyarakat Universitas Indonesia
  • Helen Andriani Departemen Administrasi dan Kebijakan Kesehatan, Fakultas Kesehatan Masyarakat Universitas Indonesia
Keywords: pharmaceutical supply, COVID-19, hospital

Abstract

Background: COVID-19 infection, which was declared a pandemic by WHO have a major impact on pharmaceutical sector. Drug shortage is one of the impacts that can affect the patient’s health and also hospital’s finances through prolonged patient care costs. The aim of this study is to assess hospital strategies to maintain pharmaceutical supply during the COVID-19 pandemic.

Methods: This research is a literature review using the PRISMA method. A literature search was performed in Scopus, Science Direct, and Springer Link using keyword pharmaceutical supply COVID-19. Studies that published between 2020 – 2021, is in English, and discussed drug supply in hospital during the COVID-19 pandemic were included. Studies were excluded if it didn’t discuss drug supply in hospital during the COVID-19 pandemic and not available in full text.

Results: A total of 3,242 articles were identified, of which 13 articles fully met the eligibility criteria and were the analyzed. Most of the studies (n=10) discussed the implementation of drug logistics during the pandemic, such as efficient drug planning, centralized drug storage, drug distribution with a unit-dose dispensing system, monitoring and reporting of drugs used every day through an appropriate database. The other three articles discuss the formation of a collaborative coordination team between medical personnel and the division of working hours on site and off site to help maintain drug supplies.

Conclusions: Efficient drug planning and an integrated information system in reporting drug availability can maintain drug supply during the COVID-19 pandemic. Collaborative HR management has an important role in supporting drug supply control through division of labor with limited staff and working time.

Downloads

Download data is not yet available.

References

Aljadeed, R. et al. (2021) ‘The impact of covid-19 on essential medicines and personal protective equipment availability and prices in Saudi Arabia’, Healthcare (Switzerland), 9(3), pp. 1–14. doi:10.3390/healthcare9030290.
Ayati, N. (2020) ‘Short and long term impacts of COVID-19 on the pharmaceutical sector’, pp. 799–805.
Dey, B.K. et al. (2021) ‘A ripple effect of covid-19 pandemic on shortage of medicinal products and its impact on patient care’, International Journal of Applied Pharmaceutics, 13(5), pp. 364–370. doi:10.22159/ijap.2021v13i5.42177.
Hua, X. et al. (2020) ‘Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic’, Journal of the American Pharmacists Association, 60(3), pp. 431-438.e1. doi:10.1016/j.japh.2020.04.006.
Hussain, K. et al. (2020) ‘Pharmacy services during COVID-19 pandemic: experience from a tertiary care teaching hospital in Pakistan’, Journal of Pharmaceutical Policy and Practice, 13(1), pp. 1–4. doi:10.1186/s40545-020-00277-5.
Ibrahim, O.M. et al. (2021) ‘Shedding the Light on Pharmacists’ Roles during COVID-19 Global Pandemic’, Saudi Pharmaceutical Journal [Preprint], (xxxx. doi:10.1016/j.jsps.2021.12.003.
Liao, Y. et al. (2020) ‘Role of pharmacists during the COVID-19 pandemic in China-Shanghai experiences’, JACCP Journal of the American College of Clinical Pharmacy, 3(5), pp. 997–1002. doi:10.1002/jac5.1288.
Liu, S. et al. (2020) ‘Providing pharmacy services during the coronavirus pandemic’, International Journal of Clinical Pharmacy, 42(2), pp. 299–304. doi:10.1007/s11096-020-01017-0.
Meng, L., Qiu, F. and Sun, S. (2020) ‘Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China’, International Journal of Clinical Pharmacy, 42(2), pp. 305–308. doi:10.1007/s11096-020-01020-5.
Moye, R.A. et al. (2021) ‘Emergency preparation and mitigation for COVID-19 response in an integrated pharmacy practice model’, American Journal of Health-System Pharmacy, 78(8), pp. 705–711. doi:10.1093/ajhp/zxab015.
Page, M.J. et al. (2021) ‘The prisma 2020 statement: An updated guideline for reporting
systematic reviews’, Medicina Fluminensis, 57(4), pp. 444–465. doi:10.21860/medflum2021_264903.
Parreiras Martins, M.A. et al. (2020) ‘Preparedness of pharmacists to respond to the emergency of the COVID-19 pandemic in Brazil: a comprehensive overview’, Drugs and Therapy Perspectives, 36(10), pp. 455–462. doi:10.1007/s40267-020-00761-7.
Pulk, R.A. et al. (2021) ‘Dynamic pharmacy leadership during the COVID-19 crisis: Optimizing patient care through formulary and drug shortage management’, American Journal of Health-System Pharmacy, 77(22), pp. 1874–1884. doi:10.1093/AJHP/ZXAA219.
Putri, R.N. (2020) ‘Indonesia dalam Menghadapi Pandemi Covid-19’, Jurnal Ilmiah Universitas Batanghari Jambi, 20(2), p. 705. doi:10.33087/jiubj.v20i2.1010.
Sami, S.A. et al. (2021) ‘A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic : moving from present to future’, Future Journal of Pharmaceutical Sciences, 9(7), pp. 1–16.
Thong, K.S. et al. (2021) ‘Pharmacy preparedness in handling COVID-19 pandemic: a sharing experience from a Malaysian tertiary hospital’, Journal of Pharmaceutical Policy and Practice, 14(1), pp. 1–4. doi:10.1186/s40545-021-00343-6.
Visacri, M.B., Figueiredo, I.V. and Lima, T. de M. (2021) ‘Role of pharmacist during the COVID-19 pandemic: A scoping review’, Research in Social and Administrative Pharmacy, 17(1), pp. 1799–1806. doi:10.1016/j.sapharm.2020.07.003.
World Health Organization (2020) WHO timeline-COVID-19. Available at: www.who.int/new-room/detail/27-04-2020-who-timeline--covid-19 (Accessed: 15 June 2020).
Wu, Y.C., Chen, C.S. and Chan, Y.J. (2020) ‘The outbreak of COVID-19: An overview’, Journal of the Chinese Medical Association, 83(3), pp. 217–220. doi:10.1097/JCMA.0000000000000270.
Yi, Z.-M. et al. (2020) ‘Mapping Evidence of Pharmacy Services for COVID-19 in China’, Frontiers in Pharmacology, 11. doi:10.3389/fphar.2020.555753.
Ying, W., Qian, Y. and Kun, Z. (2020) ‘Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID- 19 . The COVID-19 resource centre is hosted on Elsevier Connect , the company ’ s public news and information ’, (January).
Zovi, A. et al. (2021) ‘Medicines shortages and the perception of healthcare professionals working in hospitals: An Italian case study’, Journal of Interprofessional Education & Practice, 25(July), p. 100472. doi:10.1016/j.xjep.2021.100472.
Published
2022-12-28
How to Cite
Dewi, I., & Andriani, H. (2022). STRATEGI RUMAH SAKIT DALAM MENGELOLA PERSEDIAAN FARMASI SELAMA PANDEMI COVID-19. JURNAL MEDIA KESEHATAN, 15(2), 19-31. https://doi.org/https://doi.org/10.33088/jmk.v15i2.772